Home > Blog Tag

Blog Posts by Tag: Pathology

Streamlining Diagnostic Processes: How Dolbey Fusion Narrate Integrates with XIFIN LIS

Enjoy the following content from our partner, Dolbey. Thousands – or even millions – of data points can be recorded in and referenced from an LIS, but moving back and forth between the LIS and lab tests can drag down your productivity. With speech recognition, you can reference and record information in an LIS without a mouse and keyboard. One of the most powerful laboratory information...

Read


2021 CMS Proposed Medicare Physician Fee Schedule Released

On August 4, 2020 CMS released its 2021 proposed physician fee schedule. Unfortunately, under the proposed schedule, pathology and several other specialties would take the brunt of some significant reductions. This is largely the result of the redistributive effects of previously finalized changes to the office/outpatient E/M visits taking effect in 2021. The results of these reductions will have...

Read


G0416 Prostate Update for Cigna: Go-Live August 18, 2020

As announced by Cigna earlier this summer, beginning August 18, 2020 Cigna will require pathology groups to submit G0416 for prostate needle biopsies instead of 88305. Prostate biopsies will no longer be reimbursed using the 88305.XIFIN confirmed with Cigna that this applies to all Cigna plans, not just a select few. Commercial payors aligning with CMS guidelines on G codes is becoming a trend...

Read


Florida Society of Pathology Pushes to Retain PCCL Reimbursement from Medicaid

Florida Society of Pathology (FSP) held a call for members on July 15th to review the process the organization had taken upon learning the state’s Medicaid plan would no longer fund Professional Component of Clinical Laboratory (PCCL) reimbursement. Florida is among less than a handful of states, including California and Illinois, that sill receive reimbursement for PCCL charges for Medicaid...

Read


How Upcoming Changes to United Health’s Laboratory Test Registry May Impact Your Lab

Important Update:In response to the COVID-19 Public Health Emergency (PHE), UHC has made a decision to delay the implementation of the Laboratory Test Registry Protocol to January 1, 2021.  A UHC representative informed XIFIN in a July 17, 2020 correspondence, “To ensure compliance with these requirements, free-standing and outpatient hospital lab providers should register their laboratory...

Read


Routine Lab Volume in the US Sees Steep Drop, Gradual Recovery Due to COVID-19

Diagnostic laboratories remain at the forefront of US efforts to assess and control the spread of COVID-19. Diagnostics play a critical role both in the US pandemic response and also in helping the country as states establish plans to re-open. As states, and therefore laboratories, continue to focus on COVID-19 virus testing with the recent addition of antibody testing, elective and non-urgent...

Read


Pathology Volumes: Where’s the Surge?

As the laboratory market continues to feel the impact of COVID-19, one of the most hard-hit types of labs from both a decline in testing volume and revenue is pathology practices. At the beginning of the pandemic, many pathology labs immediately experienced a decline in testing volume. Based on XIFIN client data, at the lowest point, pathology volume was down 46% the week of April 13,...

Read


Appreciation for Dedicated Lab Warriors

Laboratory Professionals Week, April 19-25, is an annual celebration of lab professionals and pathologists who play a vital role in healthcare and patient advocacy.This year, Lab Week is occurring while lab professionals and pathologists are staunchly working and sacrificing on the front lines of the COVID-19 pandemic. Laboratory professionals...

Read